(redirected from chymotryptic)
Also found in: Dictionary, Medical, Wikipedia.


(kī'mōtrĭp`sĭn), proteolytic, or protein-digesting, enzymeenzyme,
biological catalyst. The term enzyme comes from zymosis, the Greek word for fermentation, a process accomplished by yeast cells and long known to the brewing industry, which occupied the attention of many 19th-century chemists.
..... Click the link for more information.
 active in the mammalian intestinal tract. It catalyzes the hydrolysishydrolysis
, chemical reaction of a compound with water, usually resulting in the formation of one or more new compounds. The most common hydrolysis occurs when a salt of a weak acid or weak base (or both) is dissolved in water.
..... Click the link for more information.
 of proteinsprotein,
any of the group of highly complex organic compounds found in all living cells and comprising the most abundant class of all biological molecules. Protein comprises approximately 50% of cellular dry weight.
..... Click the link for more information.
, degrading them into smaller molecules called peptidespeptide,
organic compound composed of amino acids linked together chemically by peptide bonds. The peptide bond always involves a single covalent link between the α-carboxyl (oxygen-bearing carbon) of one amino acid and the amino nitrogen of a second amino acid.
..... Click the link for more information.
. Peptides are further split into free amino acidsamino acid
, any one of a class of simple organic compounds containing carbon, hydrogen, oxygen, nitrogen, and in certain cases sulfur. These compounds are the building blocks of proteins.
..... Click the link for more information.
. Chymotrypsin is produced in the pancreas as the inactive, or zymogen, form chymotrypsinogen. Along with other digestive enzymes of the pancreas, chymotrypsinogen is carried in the pancreatic juicepancreatic juice
, secretions of the exocrine portion of the pancreas into the small intestine. The juice contains a number of important digestive enzymes, including trypsin, chymotrypsin, carboxypeptidase, lipase, and amylase.
..... Click the link for more information.
 through the pancreatic duct into the duodenum. There chymotrypsinogen is activated by another enzyme, trypsin, and by molecules of active chymotrypsin. Partly because it was one of the first enzymes available commercially in crystalline form, chymotrypsin has been studied extensively.



an enzyme of the hydrolase class that decomposes proteins and peptides. Chymotrypsin, which is contained in the pancreatic secretions of animals and man, participates, along with trypsin, in the decomposition of food proteins in the small intestine. It is synthesized by the cells of the pancreas in the form of the proenzyme chymotrypsinogen, which is converted under the action of trypsin in the intestine into active chymotrypsin. The activation process includes the splitting of one strictly determined peptide bond in the chymotrypsinogen molecule, which results in the conformational restructuring of the protein molecule and the final formation of the active center of chymotrypsin.

Various forms of chymotrypsin, such as chymotrypsin A, B, and C in certain mammals, have been described, differing in physicochemical properties and certain substrate specificities. Bovine chymotrypsin A, which has a molecular weight of 25,000, was obtained in crystalline form by the American chemists M. Kunitz and J. Northrop in 1935. The molecule consists of 245 amino-acid residues, which are wound into a compact globule with semiaxes measuring 33 and 16.5 angstroms. The three-dimensional structure of chymotrypsin was established by the British scientist D. Blow and his co-workers in 1967 by X-ray diffraction analysis. Numerous forms of chymotrypsin may also be formed in the process of activating chymotrypsinogen, such as the π, δ, and α forms of chymotrypsin A of cattle.

Chymotrypsin belongs to the group of serine proteinases. Its active center includes serine residues, as well as asparaginic-acid and histidine residues, which form a charge-transfer complex. As a result of the transfer of a proton from the serine residue to histidine and then from histidine to an asparaginic-acid residue, there is a negative charge on the serine residue, which acquires the ability to attack the carbonyl carbon of the hydrolyzed peptide bond. Chymotrypsin acts in an alkaline medium (pH 7.0–8.5) and splits primarily the bonds in proteins and peptides that are formed by aromatic amino acids-tyrosine, phenylalanine, and tryptophan.

Chymotrypsin has a milk-clotting action. Chymotrypsin-type enzymes have been found in lower vertebrates and insects.


Northrop, D., M. Kunitz, and R. Herriott. Kristallicheskie fermenty. Moscow, 1950. (Translated from English.)
Mosolov, V. V. Proteoliticheskie fermenty. Moscow, 1971.



A proteinase in the pancreatic juice that clots milk and hydrolyzes casein and gelatin.
References in periodicals archive ?
The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells.
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells.
7] Nonstandard abbreviations: hK, human tissue kallikrein; hK7, human stratum comeum chymotryptic enzyme (HSCCE); QPCR, quantitative reverse transcription-PCR; h-G6PDH, human glucose-6-phosphate dehydrogenase; DFS, disease-free survival; LN, lymph node; ER, estrogen receptor; PgR, progesterone receptor; and HR, hazard ratio.
b) HSCCE, human stratum corneum chymotryptic enzyme; NES1, normal epithelial cell-specific 1 gene; TLSP, trypsin-like serine protease.
b) Full gene names are as follows: hPRK, human pancreatic/renal kallikrein; hGK-1, human glandular kallikrein-1; KLK-L, kallikrein-like; EMSP1, enamel matrix serine proteinase 1; HSCTE, human stratum corneum tryptic enzyme; HSCCE, human stratum corneum chymotryptic enzyme; TADG-14, tumor-associated, differentially expressed gene-14; NES1, normal epithelial cell-specific 1 gene; TLSP, trypsin-like serine protease; PRSS, protease serine; PRSSL, protease serine-like.
To confirm that the tryptic and chymotryptic activities were attributable only to the proteasome, a proteasome inhibitor from a second structurally unrelated class was also used, clasto-lactacystin-[beta]-lactone (lactacystin).
When the proteasome chymotryptic activity in PWB or RBC lysates was measured, the same assay buffer was used except that the sodium dodecyl sulfate (SDS) concentration was 0.
Concentrations of the substrate Suc-Leu-Leu-Val-Tyr-AMC (LLVY-AMC; chymotryptic activity) were evaluated in 5 or 10 [micro]mol/L increments up to 100 [micro]mol/L.
After 1 h, heparinized blood was obtained, and WBC and PWB lysates were prepared for the chymotryptic and tryptic assays as described above.
The chymotryptic activity of the 20S proteasome typically is measured in vitro by monitoring the release of the fluorophore, AMC, from the synthetic peptide substrate, LLVY-AMC in the presence of SDS (12).